HARMONY

Discussion in 'Biotech Startups' started by anonymous, Apr 27, 2018 at 9:30 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    True all the negative jealous people that couldn’t make the cut at harmony need to get a life and we are the highest paid reps in the business
     

  2. anonymous

    anonymous Guest

     
  3. anonymous

    anonymous Guest

     
  4. anonymous

    anonymous Guest

    Thanks Jeff now go fix those jacked up teeth
     
  5. anonymous

    anonymous Guest

    You divert to insults the jealousy will continue to drive you crazy. So jealous
     
  6. anonymous

    anonymous Guest

     
  7. anonymous

    anonymous Guest

    I’ve made my career on selling products based on efficacy and safety. That’s what matters.

    The point is by selling on the scheduling is ridiculous.
    S+E is poor and not what we were lead to believe. That’s on the management team and they need to answer for it

    I Am a good sales person and so are some others but the reality is this is shit. It’s cool we are high paid- at the moment, until they realize they cannot pay all of us. I heard that was already the discussion with the big wigs.
     
  8. anonymous

    anonymous Guest

    It’s this attitude that will not succeed here. We need you focused and as a winner.

    Focus on the positives and there are many of them. If you cannot then maybe you should re evaluate where you are at

     
  9. anonymous

    anonymous Guest

    Are you dumb?
     
  10. anonymous

    anonymous Guest

    Obviously, I took this job....but hey, show me the money!
     
  11. anonymous

    anonymous Guest

    Bs.

    No one treats it or can recognize it. It’s a mute point and now we can keep a consistent message on EDS and scheduling
     
  12. anonymous

    anonymous Guest

    awh, some little crybaby didn't get called back for an interview.

     
  13. anonymous

    anonymous Guest

    It's the right approach to focus on the data and claims in hand. Agree cataplexy is a moot point in that there is no claim. That said the value of the claim would be substantial, patient survey's suggest that up to 65% of patients experience cataplexy, though MD recognition is low but a good chance to educate. It would also be a good differentiator (since only Xyrem currently has the indication) and take some focus off of the less than stellar EDS data.
     
  14. anonymous

    anonymous Guest

     
  15. anonymous

    anonymous Guest

    um Jeff Dayno.....again, look what he did to Eaglet and their label. good luck sales reps your gonna need it
     
  16. anonymous

    anonymous Guest

    Well as they say history has a way of repeating itself

    That means we’re screwed !!!!
     
  17. anonymous

    anonymous Guest

    The negative jealous people who couldn’t even get an interview much less an offer. So jealous and you should be. Sad
     
  18. anonymous

    anonymous Guest

     
  19. anonymous

    anonymous Guest

     
  20. anonymous

    anonymous Guest

    Another loser who couldn't even get a interview. Jealousy Will kill you